Fingolimod: A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.8, 2011-08, pp. : 673-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Simpson D. Noble S. Perry C.

CNS Drugs, Vol. 16, Iss. 12, 2002-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis

By Carter Natalie J. Keating Gillian M.

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1545-1577

Adis International

Access to resources Recommend Favorite

Subcutaneous Recombinant Interferon- -1a (Rebif®): A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Murdoch David Lyseng-Williamson Katherine A.

Drugs, Vol. 65, Iss. 9, 2005-01 ,pp. : 1295-1312

Adis International

Access to resources Recommend Favorite

Interferon- -1b: A Review of its Use in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By McCormack P.L. Scott L.J.

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 521-546

Adis International

Access to resources Recommend Favorite

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo Hartung Hans-Peter Kurukulasuriya Nuwan C Greenberg Steven J Scaramozza Matthew

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite